Escitalopram in Schizophrenia in OCD- Open Label Study

BeerYaakov Mental Health Center

Status and phase: Completed; Phase 4

Conditions: Schizophrenia

Treatments: Drug: Escitalopram

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00456937

Escitalopram-173CTIL

Details and patient eligibility

About

SSRI's has been demonstrated to be partially effective in schizophrenia and OCD. We therefore suggest that Escitalopram up to 20 mg /d in those patients could be effective in reducing obsessive compulsive symptomatology

Enrollment: 15 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who suffer from schizophrenia and OCD

Exclusion criteria

• Substance abuse,
• Serious medical condintions,
• Being on SSRI treatment